110 related articles for article (PubMed ID: 34777511)
1. Response to "
Fung R; Elbe D; Stewart SE
J Can Acad Child Adolesc Psychiatry; 2021 Nov; 30(4):278-279. PubMed ID: 34777511
[No Abstract] [Full Text] [Related]
2. Clomipramine in Combination with Fluvoxamine: A Potent Medication Combination for Severe or Refractory Pediatric OCD.
Hardy NE; Walkup JT
J Can Acad Child Adolesc Psychiatry; 2021 Nov; 30(4):273-277. PubMed ID: 34777510
[TBL] [Abstract][Full Text] [Related]
3. Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine.
Mundo E; Rouillon F; Figuera ML; Stigler M
Hum Psychopharmacol; 2001 Aug; 16(6):461-468. PubMed ID: 12404554
[TBL] [Abstract][Full Text] [Related]
4. New pharmacologic approaches to obsessive compulsive disorder.
Insel TR
J Clin Psychiatry; 1990 Oct; 51 Suppl():47-51; discussion 56-8. PubMed ID: 2120204
[TBL] [Abstract][Full Text] [Related]
5. Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Mundo E; Maina G; Uslenghi C
Int Clin Psychopharmacol; 2000 Mar; 15(2):69-76. PubMed ID: 10759337
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
Piccinelli M; Pini S; Bellantuono C; Wilkinson G
Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
[TBL] [Abstract][Full Text] [Related]
7. Current concepts in the pharmacological treatment of obsessive-compulsive disorder.
Zohar J; Zohar-Kadouch RC; Kindler S
Drugs; 1992 Feb; 43(2):210-8. PubMed ID: 1372219
[TBL] [Abstract][Full Text] [Related]
8. Fluvoxamine and clomipramine in the treatment of cataplexy.
Schachter M; Parkes JD
J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):171-4. PubMed ID: 6766990
[TBL] [Abstract][Full Text] [Related]
9. Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.
Klok CJ; Brouwer GJ; van Praag HM; Doogan D
Acta Psychiatr Scand; 1981 Jul; 64(1):1-11. PubMed ID: 6172005
[TBL] [Abstract][Full Text] [Related]
10. Non-competitive inhibition of clomipramine N-demethylation by fluvoxamine.
Härtter S; Arand M; Oesch F; Hiemke C
Psychopharmacology (Berl); 1995 Jan; 117(2):149-53. PubMed ID: 7753960
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH
Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
[TBL] [Abstract][Full Text] [Related]
12. Management of treatment-refractory obsessive compulsive disorder patients.
Dominguez RA; Mestre SM
J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
Bogetto F; Bellino S; Vaschetto P; Ziero S
Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782
[TBL] [Abstract][Full Text] [Related]
14. BDNF association study with obsessive-compulsive disorder, its clinical characteristics, and response to fluvoxamine-treatment in Iranian patients.
Abdolhosseinzadeh S; Alizadeh N; Shams J; Asadi S; Ahmadiani A
Exp Clin Psychopharmacol; 2020 Apr; 28(2):216-224. PubMed ID: 31180700
[TBL] [Abstract][Full Text] [Related]
15. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Milanfranchi A; Ravagli S; Lensi P; Marazziti D; Cassano GB
Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
[TBL] [Abstract][Full Text] [Related]
16. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
[TBL] [Abstract][Full Text] [Related]
17. Biological therapies for obsessive-compulsive disorder.
Fallon BA; Mathew SJ
J Psychiatr Pract; 2000 May; 6(3):113-28. PubMed ID: 15990479
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of obsessive compulsive disorder.
Goodman WK; McDougle CJ; Price LH
J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
[TBL] [Abstract][Full Text] [Related]
19. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
den Boer JA; Westenberg HG; Kamerbeek WD; Verhoeven WM; Kahn RS
Int Clin Psychopharmacol; 1987 Jan; 2(1):21-32. PubMed ID: 3117876
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
